Test Code SAL Salicylate
Specimen and Container/Tube
Specimen Type: Serum
Preferred Specimen: Red Top
Other Acceptable specimens: None
Volume
Preferred Volume: 0.5 mL
Minimum Volume: 0.2 mL
Specimen Stability
Storage Temperature |
Stability |
Room temperature |
assay immediately |
Refrigerated |
2 weeks |
Frozen |
not acceptable |
Collection Instructions
Collect specimen per standard laboratory collection procedures.
Specimen Handling and Transport Instructions
UCMC Onsite Instructions:
Collect specimen per standard collection procedure and send to laboratory immediately.
UCMC Offsite and UC MedLab Outreach Instructions:
- Samples should be centrifuged within 2 hours of collection.
- Centrifuge specimens at >2500 x g for 10 minutes at room temperature.
- Aliquot sample into plastic transport tube containing a minimum of 0.2 mL of specimen.
- Samples must be sent refrigerated at 2-8oC.
Rejection Criteria
- Common specimen rejected situations include: incorrect specimen type, insufficient volume, missing or incomplete specimen identifiers, incorrect specimen transport, or specimens outside stability limits.
- Specimens that are clotted or grossly hemolyzed.
- Specimens that were transported unspun/whole blood and draw time is greater than 6 hours.
Reference Values
Test |
Age |
Sex |
Reference Range |
Salicylate |
All |
All |
10.0 - 20.0 mg/dL |
Critical Values
Analyte |
Unit |
Low |
High |
Age |
Salicylate |
mg/dL |
N/A |
>30 |
All |
Turnaround Time
Turnaround times are relative to the time the specimen is received in the test laboratory.
STAT Turnaround Time: 1 hour
Routine Turnaround Time: 4 hours
Testing Schedule: 24/7
Clinical Indications
Salicylate measurements are used in the diagnosis and treatment of salicylate overdose and in monitoring salicylate levels to ensure appropriate therapy.
Test Components
Salicylate
Methodology
Spectrophotometric (Roche Diagnostics)
CPT Codes
80179
LOINC Codes
4024-6
Synonyms/Keyword Search
Salicylic acid
Additional Information
- Alpha-ketobutyric Acid: Positive interference at 50 mg/dL or greater. In individual patients interference from bilirubin, hemoglobin and lipemia can be significant.
Last Review Date
4/18/2025